Shared Risk Factors in Cardiovascular Disease and Cancer

Cardiovascular disease (CVD) and cancer are the 2 leading causes of death worldwide. Although commonly thought of as 2 separate disease entities, CVD and cancer possess various similarities and possible interactions, including a number of similar risk factors (eg, obesity, diabetes mellitus), suggesting a shared biology for which there is emerging evidence. Although chronic inflammation is an indispensable feature of the pathogenesis and progression of both CVD and cancer, additional mechanisms can be found at their intersection. Therapeutic advances, despite improving longevity, have increased the overlap between these diseases, with millions of cancer survivors now at risk of developing CVD. Cardiac risk factors have a major impact on subsequent treatment-related cardiotoxicity. In this review, we explore the risk factors common to both CVD and cancer, highlighting the major epidemiological studies and potential biological mechanisms that account for them.

[1]  Thomas R Frieden,et al.  CDC Health Disparities and Inequalities Report - United States, 2013. Foreword. , 2013, MMWR supplements.

[2]  Jennifer G. Robinson,et al.  2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. , 2014, Circulation.

[3]  S. Costanzo,et al.  Contemporary Reviews in Cardiovascular Medicine Cardiovascular and Overall Mortality Risk in Relation to Alcohol Consumption in Patients With Cardiovascular Disease , 2010 .

[4]  J. Myers,et al.  Exercise and Cardiovascular Health , 2003 .

[5]  D. Balzi,et al.  Doses of Insulin and Its Analogues and Cancer Occurrence in Insulin-Treated Type 2 Diabetic Patients , 2010, Diabetes Care.

[6]  D. Hayes,et al.  Heart of darkness: the downside of trastuzumab. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[7]  Anette Hjartåker,et al.  Body mass index, physical activity, and colorectal cancer by anatomical subsites: a systematic review and meta-analysis of cohort studies , 2013, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.

[8]  Tamra E. Meyer,et al.  Non-Steroidal Anti-Inflammatory Drugs Use Is Associated with Reduced Risk of Inflammation-Associated Cancers: NIH-AARP Study , 2014, PloS one.

[9]  Laura J Rasmussen-Torvik,et al.  Ideal Cardiovascular Health Is Inversely Associated With Incident Cancer: The Atherosclerosis Risk in Communities Study , 2013, Circulation.

[10]  Z. Bloomgarden,et al.  Inflammation and insulin resistance. , 2003, Diabetes care.

[11]  M. Stampfer,et al.  Mounting evidence for prediagnostic use of statins in reducing risk of lethal prostate cancer. , 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[12]  I. M. Neiman,et al.  [Inflammation and cancer]. , 1974, Patologicheskaia fiziologiia i eksperimental'naia terapiia.

[13]  D. de Freitas,et al.  [Alcohol and cancer]. , 1997, Acta medica portuguesa.

[14]  H. Seo,et al.  Effects of Vitamin Treatment or Supplements with Purported Antioxidant Properties on Skin Cancer Prevention: A Meta-Analysis of Randomized Controlled Trials , 2011, Dermatology.

[15]  Richard J. Johnson,et al.  The immunological basis of hypertension. , 2014, American journal of hypertension.

[16]  R. Marfella,et al.  Inflammatory Cytokine Concentrations Are Acutely Increased by Hyperglycemia in Humans: Role of Oxidative Stress , 2002, Circulation.

[17]  Peter Libby,et al.  Inflammation and cardiovascular disease mechanisms. , 2006, The American journal of clinical nutrition.

[18]  L. Hemkens,et al.  Risk of malignancies in patients with diabetes treated with human insulin or insulin analogues: a cohort study , 2009, Diabetologia.

[19]  S. Lipshultz,et al.  Treatment-related cardiotoxicity in survivors of childhood cancer , 2013, Nature Reviews Clinical Oncology.

[20]  P. Stattin,et al.  Blood Pressure and Risk of Cancer Incidence and Mortality in the Metabolic Syndrome and Cancer Project , 2012, Hypertension.

[21]  M. Dobbins,et al.  The Association between Obesity and Cancer Risk: A Meta-Analysis of Observational Studies from 1985 to 2011 , 2013, ISRN preventive medicine.

[22]  Raúl Baena Ruiz,et al.  Diet and cancer: risk factors and epidemiological evidence. , 2014, Maturitas.

[23]  U. Nöthlings,et al.  Lifestyle factors and mortality among adults with diabetes: findings from the European Prospective Investigation into Cancer and Nutrition–Potsdam study * , 2010, Journal of diabetes.

[24]  M. Zwahlen,et al.  Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies , 2008, The Lancet.

[25]  B. Aggarwal,et al.  Targeting Inflammatory Pathways for Prevention and Therapy of Cancer: Short-Term Friend, Long-Term Foe , 2009, Clinical Cancer Research.

[26]  D. Mozaffarian,et al.  Defining and Setting National Goals for Cardiovascular Health Promotion and Disease Reduction: The American Heart Association's Strategic Impact Goal Through 2020 and Beyond , 2010, Circulation.

[27]  P. Ridker Novel risk factors and markers for coronary disease. , 2000, Advances in internal medicine.

[28]  Tao Wang,et al.  Advances in Research on cis-9, trans-11 Conjugated Linoleic Acid: A Major Functional Conjugated Linoleic Acid Isomer , 2015, Critical reviews in food science and nutrition.

[29]  D. Prows,et al.  Mucin apoprotein expression in COPD. , 2002, Chest.

[30]  P. Katzmarzyk,et al.  Cardiovascular health metrics and accelerometer-measured physical activity levels: National Health and Nutrition Examination Survey, 2003-2006. , 2014, Mayo Clinic proceedings.

[31]  Peter Boyle,et al.  Tobacco smoking and cancer: A meta‐analysis , 2008, International journal of cancer.

[32]  F. Hu,et al.  Type 2 diabetes and risk of cancer , 2015, BMJ : British Medical Journal.

[33]  A. Algra,et al.  Long-term effect of aspirin on colorectal cancer incidence and mortality: 20-year follow-up of five randomised trials , 2010, The Lancet.

[34]  S. Bernard,et al.  Adipocyte Triglyceride Turnover Is Independently Associated With Atherogenic Dyslipidemia , 2012, Journal of the American Heart Association.

[35]  Kevin C Oeffinger,et al.  Aging and risk of severe, disabling, life-threatening, and fatal events in the childhood cancer survivor study. , 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[36]  I. Astsaturov,et al.  Molecular Pathways Molecular Pathways : Sterols and Receptor Signaling in Cancer , 2013 .

[37]  Raynoo Thanan,et al.  Oxidative Stress and Its Significant Roles in Neurodegenerative Diseases and Cancer , 2014, International journal of molecular sciences.

[38]  S. Wacholder,et al.  Risk of renal cell cancer in relation to diuretics, antihypertensive drugs, and hypertension. , 1995, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[39]  C. Friedenreich,et al.  Body size and risk of colon and rectal cancer in the European Prospective Investigation Into Cancer and Nutrition (EPIC). , 2006, Journal of the National Cancer Institute.

[40]  Dongfeng Zhang,et al.  Physical activity and risk of breast cancer: a meta-analysis of prospective studies , 2013, Breast Cancer Research and Treatment.

[41]  Dl Hoyert,et al.  National Vital Statistics Reports NCHS.pdf , 2012 .

[42]  M. Drazner Contemporary Reviews in Cardiovascular Medicine The Progression of Hypertensive Heart Disease , 2011 .

[43]  S. J. Henley,et al.  Invasive Cancer Incidence — United States, 2010 , 2014, Morbidity and Mortality Weekly Report.

[44]  R. Rosenfeld Patients , 2012, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.

[45]  S. Grundy Obesity, metabolic syndrome, and coronary atherosclerosis. , 2002, Circulation.

[46]  T. Lehtimäki,et al.  Ideal Cardiovascular Health in Childhood and Cardiometabolic Outcomes in Adulthood: The Cardiovascular Risk in Young Finns Study , 2012, Circulation.

[47]  Jiaquan Xu,et al.  Deaths: preliminary data for 2011. , 2012 .

[48]  C. Hudis,et al.  Trastuzumab-related cardiotoxicity following anthracycline-based adjuvant chemotherapy: how worried should we be? , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[49]  M. Leitzmann,et al.  A systematic review and meta-analysis of physical activity and endometrial cancer risk , 2015, European Journal of Epidemiology.

[50]  H. Adami,et al.  International renal‐cell cancer study. VIII. Role of diuretics, other anti‐hypertensive medications and hypertension , 1995, International journal of cancer.

[51]  G. Lip,et al.  Endothelial damage and angiogenesis in hypertensive patients: relationship to cardiovascular risk factors and risk factor management. , 2003, American journal of hypertension.

[52]  J. Ioannidis,et al.  Type 2 diabetes and cancer: umbrella review of meta-analyses of observational studies , 2015, BMJ : British Medical Journal.

[53]  B. Peleteiro,et al.  Dietary patterns and colorectal cancer: systematic review and meta-analysis , 2012, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.

[54]  W. Lijinsky,et al.  Pathologic Effects of Chronic Administration of Hydrochlorothiazide, with and without Sodium Nitrite, to F344 Rats , 1987, Toxicology and industrial health.

[55]  I. Pernicova,et al.  Metformin—mode of action and clinical implications for diabetes and cancer , 2014, Nature Reviews Endocrinology.

[56]  G. Armstrong,et al.  Modifiable risk factors and major cardiac events among adult survivors of childhood cancer. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[57]  B. Reddy Diet and excretion of bile acids. , 1981, Cancer research.

[58]  Hongbing Shen,et al.  Phenotypes and genotypes of insulin-like growth factor 1, IGF-binding protein-3 and cancer risk: evidence from 96 studies , 2009, European Journal of Human Genetics.

[59]  C. Friedenreich,et al.  Physical activity and cancer prevention: etiologic evidence and biological mechanisms. , 2002, The Journal of nutrition.

[60]  J. Bucher Toxicology and Carcinogenesis Studies of Furosemide (CAS No. 54-31-9) in F344/N Rats and B6C3F1 Mice (Feed Studies). , 1989, National Toxicology Program technical report series.

[61]  N. Benowitz,et al.  Cardiovascular Effects of Exposure to Cigarette Smoke and Electronic Cigarettes: Clinical Perspectives From the Prevention of Cardiovascular Disease Section Leadership Council and Early Career Councils of the American College of Cardiology. , 2015, Journal of the American College of Cardiology.

[62]  J. Neaton,et al.  Is relationship between serum cholesterol and risk of premature death from coronary heart disease continuous and graded? Findings in 356,222 primary screenees of the Multiple Risk Factor Intervention Trial (MRFIT). , 1986, JAMA.

[63]  Matthias Egger,et al.  Insulin-like growth factor (IGF)-I, IGF binding protein-3, and cancer risk: systematic review and meta-regression analysis , 2004, The Lancet.

[64]  T. Tseng,et al.  Promotion of colon carcinogenesis through increasing lipid peroxidation induced in rats by a high cholesterol diet. , 1996, Cancer letters.

[65]  D. Hu,et al.  [Rethinking, comment and query of the 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults]. , 2014, Zhonghua xin xue guan bing za zhi.

[66]  U. Goldbourt,et al.  Does diuretic therapy increase the risk of renal cell carcinoma? , 1999, The American journal of cardiology.

[67]  A. Avgerinos,et al.  Serum lipids and lipoprotein disorders in cancer patients , 1987, Cancer.

[68]  S. Litwin Cardiac remodeling in obesity: time for a new paradigm. , 2010, JACC. Cardiovascular imaging.

[69]  F. Islami,et al.  A systematic review and meta-analysis of tobacco use and prostate cancer mortality and incidence in prospective cohort studies. , 2014, European urology.

[70]  R. Cohen,et al.  Free radicals mediate endothelial cell dysfunction caused by elevated glucose. , 1992, The American journal of physiology.

[71]  U. Goldbourt,et al.  Is there an association between hypertension and cancer mortality? , 2002, The American journal of medicine.

[72]  C. la Vecchia,et al.  Light alcohol drinking and cancer: a meta-analysis. , 2013, Annals of oncology : official journal of the European Society for Medical Oncology.

[73]  Ridker Pm Novel risk factors and markers for coronary disease. , 2000 .

[74]  R. Alexander Theodore Cooper Memorial Lecture. Hypertension and the pathogenesis of atherosclerosis. Oxidative stress and the mediation of arterial inflammatory response: a new perspective. , 1995, Hypertension.

[75]  M. Stampfer,et al.  Partnerships for promoting prevention. , 2013, Circulation.

[76]  R. Lau,et al.  Dietary fibre, whole grains, and risk of colorectal cancer: systematic review and dose-response meta-analysis of prospective studies , 2011, BMJ : British Medical Journal.

[77]  M. Lazar,et al.  The hormone resistin links obesity to diabetes , 2001, Nature.

[78]  D. Reid,et al.  Patterns of dietary intake and serum carotenoid and tocopherol status are associated with biomarkers of chronic low-grade systemic inflammation and cardiovascular risk , 2014, British Journal of Nutrition.

[79]  Robert J Glynn,et al.  Alcohol Consumption and Plasma Concentration of C-Reactive Protein , 2003, Circulation.

[80]  Jeff S. Jasper,et al.  27-Hydroxycholesterol Links Hypercholesterolemia and Breast Cancer Pathophysiology , 2013, Science.

[81]  R. Burger,et al.  Use of a dummy (pacifier) during sleep and risk of sudden infant death syndrome (SIDS): population based case-control study , 2005, BMJ : British Medical Journal.

[82]  W. Ghali,et al.  Association of alcohol consumption with selected cardiovascular disease outcomes: a systematic review and meta-analysis , 2011, BMJ : British Medical Journal.

[83]  A. Chan,et al.  Aspirin for the prevention of colorectal cancer. , 2011, Best practice & research. Clinical gastroenterology.

[84]  C. Gross,et al.  Risk Prediction Model for Heart Failure and Cardiomyopathy After Adjuvant Trastuzumab Therapy for Breast Cancer , 2014, Journal of the American Heart Association.

[85]  Napoleone Ferrara,et al.  VEGF and the quest for tumour angiogenesis factors , 2002, Nature Reviews Cancer.

[86]  B. Carstensen,et al.  Diabetes and cancer (1): evaluating the temporal relationship between type 2 diabetes and cancer incidence , 2012, Diabetologia.

[87]  D. Cha,et al.  Angiotensin II stimulates the synthesis of vascular endothelial growth factor through the p38 mitogen activated protein kinase pathway in cultured mouse podocytes. , 2006, Journal of molecular endocrinology.

[88]  D. English,et al.  Red meat, chicken, and fish consumption and risk of colorectal cancer. , 2004, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[89]  R. Shephard Body-Mass Index and Mortality among 1.46 Million White Adults , 2011 .

[90]  G. Colditz,et al.  Obesity and Cancer , 2010, The oncologist.

[91]  C Michael White,et al.  Statins and Cancer Risk: A Meta-analysis , 2007 .

[92]  J. Dixon,et al.  Expert opinion on the use of anthracyclines in patients with advanced breast cancer at cardiac risk. , 2009, Annals of oncology : official journal of the European Society for Medical Oncology.

[93]  Edward Giovannucci,et al.  Diabetes and Cancer , 2010, Diabetes Care.

[94]  C. Whitney,et al.  Non-pneumococcal mitis-group streptococci confound detection of pneumococcal capsular serotype-specific loci in upper respiratory tract , 2013, PeerJ.

[95]  P. Ganz,et al.  Examining the influence of beta blockers and ACE inhibitors on the risk for breast cancer recurrence: results from the LACE cohort , 2011, Breast Cancer Research and Treatment.

[96]  U. Bauer,et al.  [Centers for Disease Control and Prevention (CDC)]. , 2000, Annales de dermatologie et de venereologie.

[97]  K Straif,et al.  Tobacco smoking and cancer: a brief review of recent epidemiological evidence. , 2004, Lung cancer.

[98]  L. Aaltonen,et al.  Lessons from functional analysis of genome-wide association studies. , 2013, Cancer research.

[99]  G. Barrera Oxidative Stress and Lipid Peroxidation Products in Cancer Progression and Therapy , 2012, ISRN oncology.

[100]  Z. Duan,et al.  Interleukin-6 signaling pathway in targeted therapy for cancer. , 2012, Cancer treatment reviews.

[101]  J. Gustafsson,et al.  On estrogen, cholesterol metabolism, and breast cancer. , 2014, The New England journal of medicine.

[102]  S. Weitzman,et al.  Chronic inflammation and cancer: the role of the mitochondria. , 2011, Oncology.

[103]  T. Choueiri,et al.  Clinical risk factors for the development of hypertension in patients treated with inhibitors of the VEGF signaling pathway , 2015, Cancer.

[104]  E. Murphy Estrogen signaling and cardiovascular disease. , 2011, Circulation research.

[105]  S. Bojesen,et al.  Statin use and reduced cancer-related mortality. , 2012, The New England journal of medicine.

[106]  A. Khera,et al.  Forecasting the Future of Cardiovascular Disease in the United States: A Policy Statement From the American Heart Association , 2011, Circulation.

[107]  S. Nie,et al.  The dose–response effect of physical activity on cancer mortality: findings from 71 prospective cohort studies , 2015, British Journal of Sports Medicine.

[108]  N. Hou,et al.  Leptin and cardiovascular diseases , 2011, Clinical and experimental pharmacology & physiology.

[109]  Z. Oltvai,et al.  Statin-induced mevalonate pathway inhibition attenuates the growth of mesenchymal-like cancer cells that lack functional E-cadherin mediated cell cohesion , 2014, Scientific Reports.

[110]  Dirk W Lachenmeier,et al.  Alcohol consumption and ethyl carbamate. , 2010, IARC monographs on the evaluation of carcinogenic risks to humans.

[111]  S. Zhong,et al.  Statin use and mortality in cancer patients: Systematic review and meta-analysis of observational studies. , 2015, Cancer treatment reviews.

[112]  J. Mclaughlin,et al.  Increased risk of renal cell cancer among women using diuretics in the United States , 1993, Cancer Causes & Control.

[113]  P. Scherer,et al.  Adipose tissue, inflammation, and cardiovascular disease. , 2005, Circulation research.

[114]  K. Sheahan,et al.  Estrogen Receptors and Their Implications in Colorectal Carcinogenesis , 2015, Front. Oncol..

[115]  R. Kaaks,et al.  Obesity , Endogenous Hormones , and Endometrial Cancer Risk : A Synthetic Review 1 , 2002 .